QQ客服 官方微博 反馈留言

	Primary endpoint Outcomes of A Prospective, Single-Blinded, Multi-Center, Randomized, Controlled, Clinical Trial on the Efficacy and Safety of Sirolimus-Eluting Stent (MiStent (R) System) compared to TIVOLI in the Treatment of Patients with Coron
	Han, Yaling; Wang, Zhiyong; Pei, Hanjun; Zhang, Li; Yang, Yuejin; Xu, Bo; Zheng, Yang; Zhang, Zheng; Hu, Xinqun; Ren, Ziwen
	2018
卷号	72期号:16页码:C120-C120
ISSN号	0735-1097
URL标识	查看原文
收录类别	SCIE
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6353281
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Han, Yaling,Wang, Zhiyong,Pei, Hanjun,et al. Primary endpoint Outcomes of A Prospective, Single-Blinded, Multi-Center, Randomized, Controlled, Clinical Trial on the Efficacy and Safety of Sirolimus-Eluting Stent (MiStent (R) System) compared to TIVOLI in the Treatment of Patients with Coron[J],2018,72(16):C120-C120.
APA	Han, Yaling.,Wang, Zhiyong.,Pei, Hanjun.,Zhang, Li.,Yang, Yuejin.,...&Jing, Quanmin.(2018).Primary endpoint Outcomes of A Prospective, Single-Blinded, Multi-Center, Randomized, Controlled, Clinical Trial on the Efficacy and Safety of Sirolimus-Eluting Stent (MiStent (R) System) compared to TIVOLI in the Treatment of Patients with Coron.,72(16),C120-C120.
MLA	Han, Yaling,et al."Primary endpoint Outcomes of A Prospective, Single-Blinded, Multi-Center, Randomized, Controlled, Clinical Trial on the Efficacy and Safety of Sirolimus-Eluting Stent (MiStent (R) System) compared to TIVOLI in the Treatment of Patients with Coron".72.16(2018):C120-C120.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。